These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23458588)

  • 1. Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.
    Yui Y; Kodama K; Hirayama A; Hosoda S; Kawai C;
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):171-5. PubMed ID: 23458588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
    Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
    Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.
    Kim-Mitsuyama S; Ogawa H; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K
    Kidney Int; 2013 Jan; 83(1):167-76. PubMed ID: 23051740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of chronic kidney disease in newly diagnosed and untreated hypertensive patients in cameroon: A cross-sectional study.
    Kamdem F; Lekpa FK; Doualla MS; Nouga YN; Sontsa OD; Temfack E; Kingue S
    Saudi J Kidney Dis Transpl; 2017; 28(5):1144-1149. PubMed ID: 28937076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal function on antihypertensive drug safety and efficacy in children.
    Watt KM; Avant D; Sherwin J; Benjamin DK; Hornik C; Benjamin DK; Li JS; Smith PB
    Pediatr Nephrol; 2018 Jan; 33(1):139-146. PubMed ID: 28779238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients.
    Masugata H; Senda S; Inukai M; Himoto T; Murao K; Hosomi N; Iwado Y; Noma T; Kohno M; Goda F
    Tohoku J Exp Med; 2011 Jun; 224(2):137-42. PubMed ID: 21617334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKD awareness and blood pressure control in the primary care hypertensive population.
    Ravera M; Noberasco G; Weiss U; Re M; Gallina AM; Filippi A; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Am J Kidney Dis; 2011 Jan; 57(1):71-7. PubMed ID: 21087817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.
    Tangkiatkumjai M; Walker DM; Praditpornsilpa K; Boardman H
    Clin Exp Nephrol; 2017 Jun; 21(3):504-512. PubMed ID: 27438073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.
    Ito S; Naritomi H; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2012 Aug; 35(8):867-73. PubMed ID: 22573200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
    García-Prieto AM; Verdalles Ú; de José AP; Verde E; Arroyo D; Aragoncillo I; Linares T; Barbieri D; Goicoechea M
    Hipertens Riesgo Vasc; 2020; 37(3):101-107. PubMed ID: 32156479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
    BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.
    Tsuchimoto A; Tanaka S; Kitamura H; Hiyamuta H; Tsuruya K; Kitazono T; Nakano T;
    Clin Exp Nephrol; 2022 Nov; 26(11):1100-1110. PubMed ID: 35927602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
    Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
    J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.
    Vidal-Petiot E; Metzger M; Faucon AL; Boffa JJ; Haymann JP; Thervet E; Houillier P; Geri G; Stengel B; Vrtovsnik F; Flamant M;
    J Am Heart Assoc; 2018 Oct; 7(19):e010278. PubMed ID: 30371309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.